We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Aspirin Found To Prevent Liver Damage

By LabMedica International staff writers
Posted on 18 Feb 2009
Aspirin may prevent liver damage in millions of people suffering from side effects of common drugs, alcohol abuse, and obesity-related liver disease, a new study suggests. More...


The study in the January 26, 2009, issue of Journal of Clinical Investigation revealed that in mice, aspirin reduced mortality caused by an overdose of acetaminophen, mostly known by the brand name Tylenol. It additionally revealed that a class of molecules known as toll-like receptor (TLR) antagonists, which block receptors known to activate inflammation, have a similar effect as aspirin. Since these agents seem to work by reducing injury-induced inflammation, the findings suggest aspirin may help prevent and treat liver damage from a host of noninfectious causes, according to Wajahat Mehal, M.D., from the section of digestive diseases and department of immunobiology at Yale School of Medicine (New Haven, CT, USA).

"Many agents such as drugs and alcohol cause liver damage, and we have found two ways to block a central pathway responsible for such liver injury,” Dr. Mehal said. "Our strategy is to use aspirin on a daily basis to prevent liver injury, but if it occurs, to use TLR antagonists to treat it.”

Potential drugs that have failed clinical trials because of liver toxicity might be revived if combined with aspirin, according to Dr. Mehal. "This offers the exciting possibility of reducing a lot of pain and suffering in patients with liver diseases, using a new and very practical approach,” concluded Dr. Mehal.

Related Links:

Yale School of Medicine




Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Online QC Software
Acusera 24•7
Pipette Calibration System
Artel PCS®
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.